| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-074 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 会议召开时间：2025 年 12 月 02 日（星期二）09:00-10:00 上海阿拉丁生化科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 11 月 25 日（星期二）至 12 月 01 日（星期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 aladdindmb@163.com 进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 上海阿拉丁生化科技股份有限公司（以下简称"公司"）已于 2025 年 10 月 30 日发布公司 2025 年 ...

Core Viewpoint - The Shanghai Municipal Science and Technology Commission has approved 8 projects under the 2025 "Scientific Instruments" key technology R&D plan, aiming to enhance the independent R&D capabilities of high-end scientific instruments and support related industry development, with a total funding of 18 million RMB [1][2][3]. Project Overview - The approved projects cover various cutting-edge scientific instruments and technology fields, including: - Miniaturized polarization-independent superconducting single-photon detectors - High-resolution, high-throughput live-cell light-sheet imaging systems - High-end anti-gas-phase surface energy analyzers - Nuclear electrochemical water quality monitoring high-end scientific instruments - Fully automatic ultra-fast visualization of biological sample freeze-thaw instruments - High-end pure water and ultra-pure water systems for the electronics industry - Development of high-end flow cytometry fluorescent dyes - Development of high-end metabolic enzymes and their activity detection reagent kits [2][4]. Funding Details - The total funding allocated for this batch of projects is 18 million RMB, with 14.4 million RMB to be disbursed in the 2025 fiscal year. The notification emphasizes that project undertakers must effectively manage and implement the projects to ensure timely completion of research objectives [3][6].

Group 1 - The company Shanghai Aladdin Biochemical Technology Co., Ltd. has undergone a share transfer due to the dissolution and liquidation of its employee stock ownership platform, Shanghai Jingzhen Cultural and Artistic Development Center (Limited Partnership), which held 7,381,190 shares, accounting for 2.22% of the company's total share capital [1] - The share transfer was completed through a non-trading transfer method, with the shares registered to the partners of Jingzhen Cultural on November 18, 2025 [1][2] - The company confirms that the non-trading transfer will not lead to any change in control or affect the governance structure and daily operations of the company [2][3] Group 2 - Company directors, supervisors, and senior management will continue to adhere to commitments made in the company's prospectus, including restrictions on share transfers during their tenure and for six months post-departure [2] - After the non-trading transfer, the partners of Jingzhen Cultural are prohibited from reducing their holdings within six months and must comply with relevant regulations regarding major shareholder reductions [3] - The new shareholders will have specific limits on share reductions, including a maximum of 1% of total shares through centralized bidding and 2% through block trading within any consecutive 90-day period [3]

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-073 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于股东完成证券非交易过户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 | 序号 | 过出方 | 过入方 | 过户数量 | 占公司总股本 | 股份性质 | | --- | --- | --- | --- | --- | --- | | 1 | | | （股） | 比例 | | | | | 招立萍 | 2374595 | 0.7139% | 无限售流通股 | | 2 | | 赵新安 | 898508 | 0.2701% | | | 3 | | 顾玮彧 | 711657 | 0.2140% | | | 4 | 上海晶真文 | 凌青 | 561327 | 0.1688% | | | 5 | 化艺术发展 | 姜苏 | 336024 | 0.1010% | | | 6 | 中心（有限合 | 马亭 | 299 ...

Core Points - Aladdin's stock price decreased by 2.04% on November 17, trading at 13.42 CNY per share with a market capitalization of 4.464 billion CNY [1] - The company has seen an 18.42% increase in stock price year-to-date, with a 1.51% rise over the last five trading days and an 11.37% increase over the last 20 days, but a 13.36% decline over the last 60 days [2] - Aladdin's main business involves the research, production, and sales of reagents, with 96.96% of revenue coming from scientific reagents [2] - As of September 30, 2025, Aladdin reported a revenue of 444 million CNY, a year-on-year increase of 17.59%, while net profit attributable to shareholders decreased by 20.41% to 57.76 million CNY [2] Financials - The company has distributed a total of 241 million CNY in dividends since its A-share listing, with 150 million CNY distributed over the last three years [3] - As of September 30, 2025, the number of shareholders decreased by 7.17% to 11,600, while the average circulating shares per person increased by 7.72% to 28,729 shares [2] Shareholder Information - The top ten circulating shareholders have seen changes, with several funds exiting the list as of September 30, 2025 [3]

Core Viewpoint - The announcement details a change in the equity structure of Shanghai Aladdin Biochemical Technology Co., Ltd., primarily due to the dissolution and liquidation of its employee stock ownership platform, Shanghai Jingzhen Cultural and Artistic Development Center (Limited Partnership), which will lead to a non-trading transfer of shares among partners without affecting the company's control or governance structure [2][9][10]. Group 1: Equity Change Details - The equity change is initiated by the dissolution of the employee stock ownership platform, which will transfer shares to its partners through a non-trading transfer [2][9]. - After the completion of this non-trading transfer, the platform will no longer hold any shares in the company, and the overall shareholding of the controlling shareholder and actual controller will decrease [3][5]. - The platform currently holds 7,381,190 shares, accounting for 2.22% of the company's total equity [9]. Group 2: Shareholding Structure - The controlling shareholder, Zhao Liping, will see an increase in her shareholding after the transfer, while the platform's shareholding will be eliminated [3][10]. - The announcement specifies that the non-trading transfer will not lead to any change in the company's control or affect its governance structure and daily operations [2][9]. Group 3: Regulatory Compliance - The company will comply with the relevant regulations, including the disclosure of a simplified equity change report and the necessary procedures for the non-trading transfer [6][10]. - The transfer process will be handled by the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [10][19].

Key Points - *ST Zhengping's stock will resume trading on November 12, 2025, after a significant increase of 152.42% from September 1 to October 28, 2025, with 21 days of trading halts and 5 instances of abnormal trading fluctuations [3] - Dongfang Zhizao plans to acquire 70% of Nantong Saifu Machinery Equipment Co., Ltd. for 27.4887 million yuan, making it a subsidiary [4] - Zhifei Biology received approval for clinical trials of a combined vaccine for adolescents and adults to prevent diphtheria, tetanus, and whooping cough [5] - CITIC Securities has been approved by the CSRC to issue up to 50 billion yuan in short-term corporate bonds [6] - Bangji Technology intends to terminate a major asset restructuring involving the acquisition of several companies, stating that current operations will not be adversely affected [7] - Dekeli is planning to issue S-shares and list on the Singapore Exchange as part of its global strategy [8] - Emei Mountain A announced that Leshan State Investment will transfer 90% of its stake in Emei Mountain Leshan Buddha Tourism Group to another state-owned entity without compensation, maintaining the current control structure [9] Performance Summary - Xincheng Development reported a contract sales amount of approximately 1.419 billion yuan in October 2025, with cumulative sales of about 16.468 billion yuan from January to October [11] - Huadong Holdings sold 242,500 pigs in October 2025, with a 19.85% month-on-month increase and a 20.80% year-on-year increase [13] - Xiamen Airport's passenger throughput in October was 2.5548 million, a year-on-year increase of 1.56% [14] Shareholding Changes - Huaguang Huaneng executives plan to reduce their holdings, with the chairman and several executives intending to sell up to 171,200 shares each [16] - Hot景 Biology announced a share buyback plan of 100 million to 200 million yuan for employee stock ownership or incentives [17] - Aladdin's controlling shareholder's stake decreased from 46.27% to 44.76% due to the dissolution of a partnership [18] - JianKai Technology's controlling shareholder plans to transfer 3% of the company's shares [19] - Yuyuan Holdings intends to repurchase shares worth 200 million to 300 million yuan at a price not exceeding 8.6 yuan per share [20] Major Contracts - China Oil Engineering's subsidiary won a project in Kazakhstan worth approximately 3.003 billion yuan for the construction of ethane and propane pipelines [22] - Dash Intelligent signed a contract for an intelligent display technology park project worth 12.7652 million yuan, which will positively impact its market share in the enterprise park sector [24]

Core Viewpoint - Aladdin (688179.SH) announced that its shareholder, Jingzhen Culture, intends to dissolve and liquidate, leading to a non-trading transfer of shares to its partners [1] Group 1: Shareholder Actions - Jingzhen Culture plans to apply for the non-trading transfer of its shares held in Aladdin to its partners through the China Securities Depository and Clearing Corporation Shanghai branch [1] - As of the announcement date, Jingzhen Culture holds 7,381,190 shares, representing 2.22% of the total share capital of Aladdin [1] Group 2: Company Structure - The executing partner of Jingzhen Culture is Zhao Liping, who is also the controlling shareholder of Aladdin [1] - Key personnel including directors, supervisors, and core technical staff are limited partners of Jingzhen Culture [1]

本次非交易过户完成后，晶真文化将不再持有公司股份，本次非交易过 户不会导致公司控制权发生变更，亦不会影响公司的治理结构和日常运营。 公司于近日收到信息披露义务人发来的《简式权益变动报告书》，现将本次 权益变动情况公告如下： 一、本次权益变动基本情况 | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-072 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于控股股东、实际控制人权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少 | | --- | --- | --- | --- | | 权益变动前合计比例 | 46.27% | | | | 权益变动后合计比例 | 44.76% | | | | 本次变动是否违反已作出的承 | 是□ | 否 | | | 诺、意向、计划 | | | | | 是否触发强制要约收购义务 | 是□ | ...

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-071 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于公司股东拟解散清算并办理公司股份非交易过 户的提示性的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 因上海阿拉丁生化科技股份有限公司（以下简称"公司"）的员工持股 平台上海晶真文化艺术发展中心（有限合伙）（以下简称"晶真文化"）拟解散 清算，晶真文化拟通过证券非交易过户的方式登记至晶真文化各合伙人名下。 截至本公告披露日，晶真文化持有公司股份为 7,381,190 股，占公司总 股本 2.22%，股东晶真文化的执行事务合伙人为公司控股股东、实际控制人招立 萍女士，公司董事/监事/高管/核心技术人员赵新安、顾玮彧、王坤、沈鸿浩、 姜苏、马亭、赵悦、凌青、海龙为晶真文化的有限合伙人。 本次非交易过户完成后，晶真文化将不再持有公司股份，本次非交易过 户不会导致公司控制权发生变更，亦不会 ...